Your browser doesn't support javascript.
loading
Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry study.
Stojkov, Igor; Conrads-Frank, Annette; Rochau, Ursula; Arvandi, Marjan; Koinig, Karin A; Schomaker, Michael; Mittelman, Moshe; Fenaux, Pierre; Bowen, David; Sanz, Guillermo F; Malcovati, Luca; Langemeijer, Saskia; Germing, Ulrich; Madry, Krzysztof; Guerci-Bresler, Agnès; Culligan, Dominic J; Kotsianidis, Ioannis; Sanhes, Laurence; Mills, Juliet; Puntscher, Sibylle; Schmid, Daniela; van Marrewijk, Corine; Smith, Alexandra; Efficace, Fabio; de Witte, Theo; Stauder, Reinhard; Siebert, Uwe.
Affiliation
  • Stojkov I; Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria.
  • Conrads-Frank A; Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria.
  • Rochau U; Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria.
  • Arvandi M; Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria.
  • Koinig KA; Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria.
  • Schomaker M; Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria.
  • Mittelman M; Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa.
  • Fenaux P; Department of Medicine A, Tel Aviv Sourasky (Ichilov) Medical Center and Sackler Medical Faculty, Tel Aviv University, Tel Aviv, Israel.
  • Bowen D; Service d'Hématologie Séniors, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris and Université Paris 7, Paris, France.
  • Sanz GF; St. James's Institute of Oncology, Leeds Teaching Hospitals, Leeds, United Kingdom.
  • Malcovati L; Department of Haematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
  • Langemeijer S; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
  • Germing U; Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.
  • Madry K; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Guerci-Bresler A; Department of Haematology, Oncology and Clinical Immunology, Universitätsklinik Düsseldorf, Düsseldorf, Germany.
  • Culligan DJ; Department of Haematology, Oncology and Internal Medicine, Warszawa Medical University, Warsaw, Poland.
  • Kotsianidis I; Service d'Hématologie Clinique, Centre Hospitalier Universitaire Brabois, Nancy, France.
  • Sanhes L; Department of Haematology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom.
  • Mills J; Department of Hematology, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece.
  • Puntscher S; Haematology Department of Perpignan, Saint Jean Hospital, Perpignan, France.
  • Schmid D; Worcestershire Acute Hospitals NHS Trust and University Hospitals Birmingham NHS Foundation Trust, Worcester, United Kingdom.
  • van Marrewijk C; Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria.
  • Smith A; Division for Quantitative Methods in Public Health and Health Services Research, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria.
  • Efficace F; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • de Witte T; Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom.
  • Stauder R; Health Outcomes Research Unit, Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA), Rome, Italy.
  • Siebert U; Department of Tumor Immunology - Nijmegen Center for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Blood Adv ; 7(12): 2772-2783, 2023 06 27.
Article in En | MEDLINE | ID: mdl-36607832
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Myelodysplastic Syndromes Type of study: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Blood Adv Year: 2023 Type: Article Affiliation country: Austria
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quality of Life / Myelodysplastic Syndromes Type of study: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Blood Adv Year: 2023 Type: Article Affiliation country: Austria